Psychological treatment of Eating Disorders: A multi-centered randomized controlled trial on the (cost-)effectiveness of Enhanced Cognitive Behavior Therapy (CBT-E) Titel for patients: Effectiveness study on the therapy of eating disorders

Psychological treatment of Eating Disorders: A multi-centered randomized controlled trial on the (cost-)effectiveness of Enhanced Cognitive Behavior Therapy (CBT-E) Titel for patients: Effectiveness study on the therapy of eating disorders - (Cost-)effectiveness study of CBT-E

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON39403

Enrollment

140

Registered

2013-04-19

Start date

2013-06-02

Completion date

Unknown

Last updated

2024-09-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Eating Disorder

Interventions

CBT-E versus TAU. TAU is the usual treatment given at the site. Depending on the site*s treatment policy, this may vary from low intensity care to high intensity care. The type of treatment provided

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adult outpatients (from age 18) with an ED diagnosis, AN, BN, EDNOS (SCID-I, with additional proposed DSM-5 criteria for BED) and a 17.5

Exclusion criteria

Exclusion criteria: The patients who will be excluded will be those whose current clinical state or circumstances make it inappropriate for them to enter treatment experiment (e.g., those at high medical or suicidal risk, psychoses), or patients who are not available for the coming 20 weeks. (For specific exclusion criteria see Research Protocol page 15).

Design outcomes

Primary

Measure	Time frame
The primary treatment outcome measure is the post treatment Eating Disorder level. This is assessed with the SCID-I.	—

Secondary

Measure	Time frame
Secondary treatment outcome measures are the level of eating disorder pathology (EDE-Q), the presence of common mental disorders (WSQ), self-esteem (RSE/ IAT), perfectionism (F-MPS), interpersonal problems (IPP-32) and anxiety and depression symptoms (MASQ). The cost-effectiveness measures are health related quality of life (EQ-5D and SF-36), service receipt and productivity losses (TiC-P; SF-HLQ), including use of mental and primary health care, social services, out-of-pocket expenditures, travel costs and waiting time (TiC-P; SF-HLQ). The CarerQoL is used to measure and value the subjective burden of informal care in terms of well-being.	—

Measure

Time frame

Secondary treatment outcome measures are the level of eating disorder pathology (EDE-Q), the presence of common mental disorders (WSQ), self-esteem (RSE/ IAT), perfectionism (F-MPS), interpersonal problems (IPP-32) and anxiety and depression symptoms (MASQ). The cost-effectiveness measures are health related quality of life (EQ-5D and SF-36), service receipt and productivity losses (TiC-P; SF-HLQ), including use of mental and primary health care, social services, out-of-pocket expenditures, travel costs and waiting time (TiC-P; SF-HLQ). The CarerQoL is used to measure and value the subjective burden of informal care in terms of well-being.

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)